Market Indices
Sector Heatmap
ABUS — Arbutus Biopharma Corporation Common Stock
NasdaqArbutus Biopharma Corporation Common Stock
- O
- 4.77
- H
- 4.78
- L
- 4.51
- V
- 16.62M
ABUS — Latest News & Headlines
10 StoriesABUS Stock Price, Quote & Chart - ChartMill
ABUS Stock Price, Quote & Chart ChartMill
Arbutus Biopharma Stock Price Forecast. Should You Buy ABUS? - StockInvest.us
Arbutus Biopharma Stock Price Forecast. Should You Buy ABUS? StockInvest.us
About 23% of Arbutus shares are being bought back for $230 million. - stocktitan.net
About 23% of Arbutus shares are being bought back for $230 million. stocktitan.net
Arbutus Biopharma (ABUS) Shares Rise on $230M Share Buyback Comp - GuruFocus
Arbutus Biopharma (ABUS) Shares Rise on $230M Share Buyback Comp GuruFocus
ABUS261016C00007000 Interactive Stock Chart | ABUS Oct 2026 7.000 call Stock - Yahoo Finance
ABUS261016C00007000 Interactive Stock Chart | ABUS Oct 2026 7.000 call Stock Yahoo Finance
Arbutus Biopharma Announces Preliminary Results of US$230 Million Substantial Issuer Bid Tender Offer - Quiver Quantitative
Arbutus Biopharma Announces Preliminary Results of US$230 Million Substantial Issuer Bid Tender Offer Quiver Quantitative
SPCX Stock Extends Post-IPO Rout: Starship Launch Scrub Deepens Slide As Short Sellers Build $25B Bear Bet - Stocktwits
SPCX Stock Extends Post-IPO Rout: Starship Launch Scrub Deepens Slide As Short Sellers Build $25B Bear Bet Stocktwits
The share offer capped at $230M has expired. Arbutus (ABUS) announces final results. - stocktitan.net
The share offer capped at $230M has expired. Arbutus (ABUS) announces final results. stocktitan.net
An up-to-$230M share offer expired; Arbutus Biopharma (ABUS) announced preliminary results. - stocktitan.net
An up-to-$230M share offer expired; Arbutus Biopharma (ABUS) announced preliminary results. stocktitan.net
Arbutus Biopharma’s US$230 Million Share Buyback Oversubscribed - TipRanks
Arbutus Biopharma’s US$230 Million Share Buyback Oversubscribed TipRanks